Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Molecular Warehouse Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11104
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found in glucose monitors. Molecular Warehouse made the successful point of care diagnostic, glucose monitors, universal by allowing people to carry out molecular diagnostic tests on their smartphones swiftly, economically and accurately, among others. Molecular Warehouse provides a patient-centric healthcare model that enables people to monitor their health regularly from anywhere. Molecular Warehouse is headquartered in Guildford, the UK.

Molecular Warehouse Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Warehouse Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Molecular Warehouse Secures USD0.9 Million in Venture Funding from Crowdcube 10
Molecular Warehouse Secures USD0.36 Million in Venture Funding 11
Molecular Warehouse Secures USD0.93 Million in Venture Funding from Oxford Technology 12
Molecular Warehouse Raises Funds in Financing 13
Molecular Warehouse Ltd – Key Competitors 14
Molecular Warehouse Ltd – Key Employees 15
Molecular Warehouse Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Warehouse Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Warehouse Secures USD0.9 Million in Venture Funding from Crowdcube 10
Molecular Warehouse Secures USD0.36 Million in Venture Funding 11
Molecular Warehouse Secures USD0.93 Million in Venture Funding from Oxford Technology 12
Molecular Warehouse Raises Funds in Financing 13
Molecular Warehouse Ltd, Key Competitors 14
Molecular Warehouse Ltd, Key Employees 15
Molecular Warehouse Ltd, Other Locations 16

List of Figures
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Molecular Warehouse Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Warehouse Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Molecular Warehouse Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marksmen Energy Inc (MAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • Adam & Company PLC:企業の戦略・SWOT・財務分析
    Adam & Company PLC - Strategy, SWOT and Corporate Finance Report Summary Adam & Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • Shenzhen Century Plaza Hotel Co., Ltd.:企業の戦略・SWOT・財務情報
    Shenzhen Century Plaza Hotel Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shenzhen Century Plaza Hotel Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Schindler Holding Ltd.:戦略・SWOT・企業財務分析
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Charoen Pokphand Foods Public Company Limited:企業の戦略・SWOT・財務情報
    Charoen Pokphand Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Charoen Pokphand Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Orascom Construction Ltd (OC):企業の財務・戦略的SWOT分析
    Summary Orascom Construction Ltd (Orascom Construction) is an engineering and construction contracting company which concentrates on large industrial, commercial and infrastructure projects. The company offers services, which include civil engineering works, buildings construction and industrial com …
  • Symbolic Displays Inc:企業の戦略・SWOT・財務情報
    Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Precipio Inc (TBIO):医療機器:M&Aディール及び事業提携情報
    Summary Precipio Inc (Precipio), formerly Transgenomic Inc, is a developer and provider of diagnostic tools and services. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services …
  • 1-800-FLOWERS.COM, Inc.:戦略・SWOT・企業財務分析
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Hochschild Mining plc:企業の戦略・SWOT・財務情報
    Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report Summary Hochschild Mining plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Frontera Energy Corp (FEC):企業の財務・戦略的SWOT分析
    Frontera Energy Corp (FEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • KUKA AG (KU2):企業の財務・戦略的SWOT分析
    KUKA AG (KU2) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Grid2020, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Broncus Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies. The company’s products comprise lungpoint virtual bronchoscopic navigation system, lungpoint satellite planning system, and flexneed …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Acorn Energy, Inc. (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • University of Chicago-製薬・医療分野:企業M&A・提携分析
    Summary University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biolo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆